Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals
Datos Bibliográficos
| ID | 14908618 |
|---|---|
| Autores | Harriet D Gliddon (0000-0002-9623-4252, University of Bristol), Zoë Ward (0000-0002-0268-988X, University of Bristol), Ellen Heinsbroek (0000-0002-2874-6280, UK Health Security Agency), Sara Croxford (0000-0003-2220-623X), Claire Edmundson (0000-0002-2335-4878, UK Health Security Agency), Vivian Hope (0000-0001-5712-5734, Liverpool John Moores University), V D Hope, Ruth Simmons (0000-0001-8156-0146, UK Health Security Agency), Holly Mitchell (0000-0002-6103-9975, UK Health Security Agency), Matthew Hickman (0000-0001-9864-459X, University of Bristol), Peter Vickerman (0000-0002-8291-5890, University of Bristol), Jack Stone (0000-0002-4584-0068, University of Bristol, autor de correspondencia) |
| Año | 2025 |
| Volumen | 144 |
| Número | Pt 1 |
| Páginas | 104324 |
| Fecha de publicación | 2025-10-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2024.104324 |
| PMID | 38218700 |
| OpenAlex | W4390811090 |
| Idioma | EN |
| Referencias citadas | 36 |
COC stages from seeing a specialist onwards improved after DAAs became widely available. Further improvements in HCV testing are needed to eliminate HCV in England
Chronic hepatitis · Family medicine · Hepatitis C · Hepatitis C virus · Logistic regression · Virus · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Internal Medicine · Virology
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs
Time matters
Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
The promise of treatment as prevention for hepatitis C
Mapping the hepatitis C cascade of care in people attending drug treatment services in England
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison
The impact of Covid-19 restrictions on needle and syringe programme provision and coverage in England
Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |